Insulin requirements during pregnancy in women with type 1 diabetes treated with insulin pump

Diabetes Metab Res Rev. 2024 Mar;40(3):e3771. doi: 10.1002/dmrr.3771.

Abstract

Introduction: Insulin requirement in women with Type 1 diabetes (T1DM) changes throughout pregnancy. The aim of this study was to determine the total change in insulin requirements and the effect of gestational weight gain (GWG) and pre-gestational BMI on insulin requirements during pregnancy in women with T1DM treated with continuous subcutaneous insulin infusion and continuous glucose monitoring.

Methods: This historical cohort study included all consecutive women with T1DM who were monitored during pregnancy at the high-risk pregnancy clinic at a tertiary medical center during April 2011-April 2019. One Way Repeated Measures ANOVA with Bonferroni adjustment was conducted to compare the effects of gestational age on insulin requirements and a Two Way Repeated Measures ANOVA was employed to test for the interaction between gestational age intervals and maternal BMI and GWG.

Results: Data regarding insulin requirements of 185 pregnancies were included in the analyses. There was a significant effect of gestational age on total insulin (Wilks' Lambda = 0.34, F(6,14) = 4.52, p = 0.009), basal insulin (Wilks' Lambda = 0.41, F(6,14) = 3.30, p = 0.031) and bolus insulin (Wilks' Lambda = 0.43, F(6,14) = 3.02, p = 0.041). Total insulin/kg requirements increased by 5.5% from 13-20 weeks to 20-26 weeks, 19% from 20-26 weeks to 26-33 weeks, and 17.4% from 26 to 33 weeks to delivery (p for trend = 0.009). Overall, insulin requirements increased by 42.1% from conception to delivery (p < 0.01). There was no significant main effect of maternal BMI or GWG on insulin requirements.

Conclusions: There is a significant increase in insulin requirements per kg during pregnancy in women with T1DM who were treated with an insulin pump.

Keywords: insulin pump; insulin requirements; pregestational diabetes; type 1 diabetes.

MeSH terms

  • Blood Glucose
  • Blood Glucose Self-Monitoring
  • Body Mass Index
  • Cohort Studies
  • Diabetes Mellitus, Type 1* / drug therapy
  • Diabetes, Gestational*
  • Female
  • Humans
  • Insulin / therapeutic use
  • Insulin, Regular, Human
  • Pregnancy
  • Pregnancy Outcome
  • Retrospective Studies

Substances

  • Insulin
  • Blood Glucose
  • Insulin, Regular, Human